69 results
Page 2 of 4
8-K
EX-99.2
12ggwutmyem0 9d
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-10.1
0di 585okdb7nm49b4l
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
92zucgfg4 op
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.1
hjk8mcjjzs7oz1b6
7 Jun 22
Other Events
4:06pm
8-K
EX-99.1
r9vcm sp0
9 May 22
Annexon Biosciences Highlights Portfolio Progress and Key Anticipated Milestones, and Reports First Quarter 2022 Financial Results
4:20pm
8-K
EX-99.1
3tsd5
7 Apr 22
Annexon Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor, ANX007, in Patients with Geographic Atrophy
5:27pm
8-K
EX-99.1
1eklnkw piv7y1l8
10 Jan 22
Regulation FD Disclosure
6:40am
8-K
EX-99.1
9bc1bm40 hrlk5
4 Jan 22
ANX005 Has Been Generally Well-Tolerated and Has Shown Full Target Engagement of C1q in the CSF
4:16pm
8-K
EX-99.1
zz770b
9 Nov 21
Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results
4:16pm
8-K
EX-99.1
sg9prkw
4 Oct 21
Departure of Directors or Certain Officers
4:06pm
8-K
EX-99.1
ljd7mio6z4pu9m
16 Aug 21
Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update
4:11pm
8-K
EX-99.1
4jzrhb2ncg ss2
17 May 21
Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial Results
4:17pm
DEF 14A
hirnsqz cuw160e0zg0n
22 Apr 21
Definitive proxy
4:06pm
8-K
EX-99.1
ddqc7cewg3pqgq irb
25 Mar 21
Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results
7:20am
10-K
pr7gn
25 Mar 21
Annual report
7:16am